These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 21119617)

  • 1. The complex and evolving story of T cell activation to AAV vector-encoded transgene products.
    Mays LE; Wilson JM
    Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.
    Siders WM; Shields J; Kaplan J; Lukason M; Woodworth L; Wadsworth S; Scaria A
    Hum Gene Ther; 2009 Jan; 20(1):11-20. PubMed ID: 18828728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV as an immunogen.
    Vandenberghe LH; Wilson JM
    Curr Gene Ther; 2007 Oct; 7(5):325-33. PubMed ID: 17979679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.
    McIntosh JH; Cochrane M; Cobbold S; Waldmann H; Nathwani SA; Davidoff AM; Nathwani AC
    Gene Ther; 2012 Jan; 19(1):78-85. PubMed ID: 21716299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.
    Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM
    J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans.
    Gernoux G; Gruntman AM; Blackwood M; Zieger M; Flotte TR; Mueller C
    Mol Ther; 2020 Mar; 28(3):747-757. PubMed ID: 31982038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer.
    Boisgerault F; Mingozzi F
    Curr Gene Ther; 2015; 15(4):381-94. PubMed ID: 26122097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver induced transgene tolerance with AAV vectors.
    Keeler GD; Markusic DM; Hoffman BE
    Cell Immunol; 2019 Aug; 342():103728. PubMed ID: 29576315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
    Costa Verdera H; Kuranda K; Mingozzi F
    Mol Ther; 2020 Mar; 28(3):723-746. PubMed ID: 31972133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of CpG Sequences on Capsid-Specific CD8
    Xiang Z; Kurupati RK; Li Y; Kuranda K; Zhou X; Mingozzi F; High KA; Ertl HCJ
    Mol Ther; 2020 Mar; 28(3):771-783. PubMed ID: 31839483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.
    Cramer ML; Shao G; Rodino-Klapac LR; Chicoine LG; Martin PT
    Hum Gene Ther; 2017 Jun; 28(6):493-509. PubMed ID: 28345428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep.
    Davey MG; Riley JS; Andrews A; Tyminski A; Limberis M; Pogoriler JE; Partridge E; Olive A; Hedrick HL; Flake AW; Peranteau WH
    PLoS One; 2017; 12(1):e0171132. PubMed ID: 28141818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression.
    Gil-Fariña I; Di Scala M; Vanrell L; Olagüe C; Vales A; High KA; Prieto J; Mingozzi F; Gonzalez-Aseguinolaza G
    PLoS One; 2013; 8(7):e67748. PubMed ID: 23844082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
    Ertl HCJ; High KA
    Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.
    Mingozzi F; Meulenberg JJ; Hui DJ; Basner-Tschakarjan E; Hasbrouck NC; Edmonson SA; Hutnick NA; Betts MR; Kastelein JJ; Stroes ES; High KA
    Blood; 2009 Sep; 114(10):2077-86. PubMed ID: 19506302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses.
    Gao G; Wang Q; Calcedo R; Mays L; Bell P; Wang L; Vandenberghe LH; Grant R; Sanmiguel J; Furth EE; Wilson JM
    Hum Gene Ther; 2009 Sep; 20(9):930-42. PubMed ID: 19441963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
    Louis Jeune V; Joergensen JA; Hajjar RJ; Weber T
    Hum Gene Ther Methods; 2013 Apr; 24(2):59-67. PubMed ID: 23442094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.